Scientists are working on a new method to cure cancer and have shown they can genetically program certain bacteria to invade the tumour cells of cancerous mice.
Academic rigor, journalistic flair
Articles on Cancer treatment
Displaying 61 - 80 of 84 articles
We should celebrate these amazing insects, not splat them.
Glioblastoma is an aggressive form of brain cancer that has a very poor prognosis. Despite the current best therapies half its sufferers survive for 15 months and less than 5% are alive after 5 years.
New research that more isn’t better when it comes to chemotherapy mirrors the evolution of surgery approaches to breast cancer that, a few decades ago, were far more radical than now.
Should new understandings of how cancers develop and could be targeted mean we should change the way the scheme registers cancer drugs?
Research shows exercise can improve outcomes of cancer patients while driving down health-care costs.
The cost of cancer drugs is killing patients and it needs to stop
Researchers believe that combining immunotherapy with traditional therapies such as radiation could open up new possibilities for cancer treatment.
The dramatic improvements in survival for children with cancer depend on clinical trials, and these trials depend on parents understanding the possible risks and benefits involved.
Obama’s goal of “curing” cancer is unrealistic, simplistic and not achievable. Cancer is a group of more than 100 different diseases for which no single cure will ever be effective.
New treatment options for cancer have flowed from our knowledge of how cells work, including the realisation the patient’s own immune system is a powerful agent in defeating cancer.
Personalised medicine is based on the idea that by understanding the specific molecular code of a person’s disease, and particularly its genetic makeup, we can more accurately tailor treatment.
A growing body of research evidence shows being married greatly increases patients’ chances of being cured of cancer.
Keytruda® is the latest drug to be registered in Australia for the treatment of widespread melanoma. But we must wait to see if it meets the cost-effectiveness targets for PBS subsidisation.
After treatment ends, many cancer survivors are left with sexual changes that, when left unaddressed, can become long-term problems.
Cancer drug cisplatin was accidentally discovered to help treat cancer in 1965. And it’s been doing exactly that since it was approved for use in 1978.
It sounds like a scene from a science fiction novel – an army of tiny weaponised robots travelling around a human body, hunting down malignant tumours and destroying them from within. But research in Nature…
Sperm grown from the frozen testicle tissue of newborn mice has been used to produce healthy offspring, according to a new…
The way melanoma cells manage tangled DNA could explain why they rapidly develop resistance to cancer treatment. Researchers…
A protein that regulates height could be used to treat diseases such as cancer and diabetes, according to new Australian…
Top contributors
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
University Distinguished Professor of Marketing, Mays Business School; Senior Fellow, Institute for Healthcare Improvement, Texas A&M University
-
Professor of Exercise Medicine, Edith Cowan University
-
Veronique Chachay is a Friend of The Conversation.
Research & Teaching Academic, The University of Queensland
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Behavioural Ecology, UCL
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Lecturer in Robotics, University of Bristol
-
Associate Professor, Cornell University
-
Professor of Experimental Cancer Therapeutics, Institute of Cancer Research, London
-
Lecturer in Speech Pathology, The University of Queensland
-
Dean, Graduate Research, University of Canberra
